Leukemia Research
Volume 26, Issue 11 , Pages 979-984, November 2002

Detection of c-kit point mutation Asp-816 → Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia

  • Karl Sotlar

      Affiliations

    • Institute of Pathology, University of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-7071-298-2265; fax: +49-7071-292-258.
  • ,
  • Claudius Fridrich

      Affiliations

    • Institute of Pathology, University of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany
  • ,
  • Adelheid Mall

      Affiliations

    • Institute of Pathology, University of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany
  • ,
  • Ralf Jaussi

      Affiliations

    • Institute of Pathology, University of Cologne, Cologne, Germany
  • ,
  • Burkhard Bültmann

      Affiliations

    • Institute of Pathology, University of Tübingen, Liebermeisterstraße 8, D-72076 Tübingen, Germany
  • ,
  • Peter Valent

      Affiliations

    • Department of Internal Medicine I, Division of Hematology and Hemostaseology, University of Vienna, Vienna, Austria
  • ,
  • Hans-Peter Horny

      Affiliations

    • Institute of Pathology, Medical University of Lübeck/MUL, Lübeck, Germany

Received 15 November 2001; accepted 19 February 2002.

Abstract 

The c-kit mutation Asp-816→Val is detectable not only in neoplastic mast cells (MCs) in patients with systemic mastocytosis (SM) but also in most associated hematologic non-MC lineage disease (AHNMD). In order to prove a monoclonal disease evolution we investigated DNA of pooled microdissected single cells for the presence of the mutation in a patient with SM and concomitant chronic myelomonocytic leukemia (CMML). LightCycler melting curve analysis and direct sequencing of nested polymerase chain reaction (PCR) products revealed the c-kit mutation in tryptase-positive MC and in leukemic CD15-positive cells in bone marrow infiltrates, but not in colonic epithelial cells, thus, suggesting a monoclonal evolution of SM and concurrent CMML on the basis of a somatic mutation in a common hematologic progenitor.

Abbreviations:  AHNMD, associated hematologic non-MC lineage disease, AML, acute myeloid leukemia, ASM, aggressive systemic mastocytosis, Asp, asparagine, BM, bone marrow, CMML, chronic myelomonocytic leukemia, EDTA, ethylenediaminetetra-acetic acid, ISM, insolent systemic mastocytosis, MC, mast cell, MCL, mast cell leukemia, MDS, myelodysplastic syndrome, MPS, myeloproliferative syndrome, PCR, polymerase chain reaction, SCF, stem cell factor, SM, systemic mastocytosis, U, unit, UP, urticaria pigmentosa, Val, valine

Keywords:  Mast cells, Microdissection, c-kit, Point mutation, Tryptase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(02)00041-3

Leukemia Research
Volume 26, Issue 11 , Pages 979-984, November 2002